Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111100851B discloses high-efficiency TbSADH mutants for synthesizing chiral biaryl alcohols with >99% ee, offering a green alternative to metal catalysis.
Novel TbSADH mutants enable high-yield synthesis of chiral biaryl alcohols. Efficient biocatalysis for pharmaceutical intermediates with superior stereoselectivity.
Patent CN114736882B reveals high-efficiency biocatalysis for antiviral intermediates. Offers supply chain stability and cost reduction in API manufacturing without heavy metals.
Novel aminotransferase mutants enable high-yield sitagliptin synthesis. Cost-effective, scalable pharma intermediate solution with >99% ee.
Novel Ti-catalyzed method offers mild conditions and high yields for beta-aminocarboxylate production, ensuring cost-effective supply chain solutions.
Novel transaminase mutant enables high-yield sitagliptin intermediate synthesis with superior stereoselectivity and scalable biocatalytic process efficiency for global supply.
Patent CN113200993A details a novel metal-free synthesis of oxindole spirodihydrofurans using organocatalysis and iodine, offering cost-effective API intermediate manufacturing.
Patent CN116082390A reveals a novel diethylzinc catalyzed route for organostannane preparation offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN107889505B reveals a novel enzymatic route for NMN production, eliminating expensive PRPP substrates to ensure cost-effective and scalable supply chain solutions.
Patent CN107922952B enables cost-effective NMN synthesis without PRPP. Discover scalable biocatalytic routes for high-purity pharmaceutical intermediates.
Patent CN110016042B reveals a novel catalytic method for synthesizing dicoumarin derivatives, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN111057729B reveals enzymatic synthesis for high-purity Larotrectinib intermediates. Discover cost-effective, scalable biocatalytic manufacturing solutions.
Patent CN111732542A details a novel synthesis for chiral NN-dioxide ligands featuring axial binaphthyl skeletons, offering enhanced stereocontrol and scalable manufacturing for fine chemical applications.
Patent CN104892540B reveals ionic liquid catalysis for naphthooxazinone derivatives offering green synthesis and supply chain advantages for reliable pharmaceutical intermediates supplier.
Patent CN111732542A details a novel chiral ligand synthesis. We offer scalable manufacturing, cost reduction in asymmetric catalysis, and reliable supply chain solutions.
Patent CN108484517B reveals a metal-free benzoxazole synthesis using NHPI and air. Discover cost-effective, scalable routes for high-purity pharmaceutical intermediates.
Patent CN117701523A reveals solvent-tolerant transaminase for high-purity sitagliptin intermediate manufacturing with significant supply chain cost reduction.
Patent CN111057729A details a green enzymatic route for Larotretinib intermediates, offering high ee values and cost reduction in API manufacturing.
Patent CN113061594A reveals novel immobilized transaminase mutants for sitagliptin synthesis, offering superior stability in aqueous isopropanol and reduced manufacturing costs.
Patent CN113061594A details a robust immobilized transaminase process for sitagliptin intermediates, offering superior stability and simplified solvent systems for cost-effective API manufacturing.